opc/atrophy

Lyen an sove nan clipboard la

Chwazi kalite sòt

Paj 1 soti nan 33 rezilta yo

Memory deterioration based on the tobacco smoke exposure and methylazoxymethanol acetate administration vs. aripiprazole, olanzapine and enrichment environment conditions.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Enrichment environment conditions, as well as tobacco smoke exposure, may affect cognitive function (e.g. spatial memory) in an animal model of schizophrenia and schizophrenic patients. The aim of this study was to find whether spatial memory function impairment is found in methylazoxymethanol

Delusional parasitosis in a patient with brain atrophy and renal failure treated with aripiprazole: case report.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Switching patients to aripiprazole from other antipsychotic agents: a multicenter randomized study.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

BACKGROUND Switching patients from one antipsychotic to another can lead to tolerability problems or transient symptom exacerbations. It is important to compare switching strategies to determine which methods produce the best possible patient outcomes. OBJECTIVE To investigate the efficacy, safety

Effect of combined administration of aripiprazole and fluoxetine on cognitive functions in female rats exposed to ethyl alcohol.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Alcoholism is a chronic and recurrent disease. The studies on ethyl alcohol show a progressive deterioration of cognitive functions (motor hyperactivity, operating memory). The aim of the study was to establish whether combined single and chronic administration of aripiprazole (ARI) and fluoxetine

Clozapine-induced hyperlipidemia resolved after switch to aripiprazole therapy.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

OBJECTIVE To report a case of severe clozapine-induced hypercholesterolemia and hypertriglyceridemia that resolved after therapy was switched to aripiprazole. METHODS A 42-year-old white man with schizoaffective disorder experienced new-onset hyperlipidemia with the addition of clozapine therapy.

Evaluation of antidepressant and memory-improving efficacy of aripiprazole and fluoxetine in alcohol-preferring rats.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

OBJECTIVE Dependence on ethanol increases the risk of depression in patients and leads to a damage and deficiencies of brain function, which manifest in cognitive functions impairment. Aripiprazole (ARI) is an atypical antipsychotic drug, which has also been shown to have a beneficial effect on

Evaluation of the antidepressant, anxiolytic and memory-improving efficacy of aripiprazole and fluoxetine in ethanol-treated rats.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Some study results indicate a positive effect of aripiprazole (ARI) on impaired cognitive functions caused by brain damage resulting from chronic EtOH abuse. However, other research shows that to manifest itself, an ARI antidepressant effect requires a combined therapy with another selective

A safety evaluation of aripiprazole for treating schizophrenia during pregnancy and puerperium.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

BACKGROUND Aripiprazole (ARI) is a second-generation antipsychotic acting as a dopamine-serotonin system stabilizer and partial agonist at D2 receptors. The drug is indicated in several and severe psychiatric disorders which are particularly frequent in women during the childbearing age. METHODS A

[Delusional parasitosis associated with dialysis treated with aripiprazole].

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

We report the case of a 75-year-old Chinese lady that presented delusional parasitosis with visual hallucinations four months after starting peritoneal dialysis. This psychosis is characterized by the persistent and unshakable belief of being infested with small living organisms, although there is

Effect of adjunctive treatment with aripiprazole to atypical antipsychotics on cognitive function in schizophrenia patients.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Second-generation antipsychotics yield only a modest improvement in cognitive benefit compared to first-generation antipsychotics. Aripiprazole, which is a partial dopamine D2 receptor agonist, may have an impact on cognitive dysfunction in patients with schizophrenia. This study administered

Aripiprazole: new drug. Just another neuroleptic.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

(1) Neuroleptics are the standard treatment for schizophrenia. The first drugs of this class, such as haloperidol, were marketed nearly 50 years ago, and neuroleptics released over the past 15 last years have provided no major advance. (2) Aripiprazole is a new neuroleptic licensed for the treatment

Aripiprazole for acute mania in an elderly person.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

New-onset bipolar disorder is rare in the elderly. Symptom profile is similar to that in young adults but the elderly are more likely to have neurological co-morbidities. There are no case reports of elderly mania being treated with aripiprazole, an atypical antipsychotic. A 78-year-old gentleman

Aripiprazole-induced chorioretinopathy: multimodal imaging and electrophysiological features.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

OBJECTIVE To report the first documented case of aripiprazole-induced chorioretinopathy. RESULTS A 47-year-old schizophrenic patient with loss of vision due to an atypical retinopathy was investigated. She had been treated with aripiprazole for 8 years. Multimodal imaging showed in the right eye a

Clozapine, ziprasidone and aripiprazole but not haloperidol protect against kainic acid-induced lesion of the striatum in mice, in vivo: role of 5-HT1A receptor activation.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Excessive activation of non-NMDA receptors, AMPA and kainate, contributes to neuronal degeneration in acute and progressive pathologies, possibly including schizophrenia. Because 5-HT(1A) receptor agonists have neuroprotective properties (e.g., against NMDA-induced neurotoxicity), we compared the

Aripiprazole once-monthly 400 mg for long-term maintenance treatment of schizophrenia: a 52-week open-label study.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

BACKGROUND Long-term maintenance treatment with an antipsychotic is often required to prevent relapse and mitigate functional deterioration in patients with schizophrenia. OBJECTIVE This study assessed the long-term safety, tolerability, and maintenance of the therapeutic effect of aripiprazole

Antre nan paj
facebook nou an

Herbal & Natural Medicine

Baz done ki pi konplè remèd fèy medsin te apiye nan syans

Travay nan 55 lang
Geri èrbal te apiye nan syans
Remèd fèy rekonesans pa imaj
Kat entèaktif GPS - tag zèb sou kote (vini byento)
Li piblikasyon syantifik ki gen rapò ak rechèch ou an
Search remèd fèy medsin pa efè yo
Izeganize enterè ou yo ak rete kanpe fè dat ak rechèch la nouvèl, esè klinik ak rive

Tape yon sentòm oswa yon maladi epi li sou remèd fèy ki ta ka ede, tape yon zèb ak wè maladi ak sentòm li itilize kont.
* Tout enfòmasyon baze sou rechèch syantifik pibliye